45 digests, newest first, page 2 of 3, browse the folder on GitHub
Sep 16, 2026, 10 items
Biotech companies often struggle to identify which patients will respond well to GLP1 therapies early on.
Also covers AI for R&D - Human Control, Longevity Vaccines, Dancing for Health and 6 more.
Sep 14, 2026, 10 items
Tarlatamab monitoring has been updated for C1D1 + C1D8, reducing the observation period to 22-24 hours.
Also covers Lung Cancer Treatment - Gotistobart Improved Overall Survival, Radiology Rewired - Vessel Occlusion Detection, AI Model Predicts Immunotherapy Outcomes and 6 more.
Sep 14, 2026, 9 items
Trusted Regulatory Spaces (TRS) is a shared regulatory infrastructure that provides secure spaces, trusted tools, controlled data exchange, and auditable collaboration...
Also covers AI & Healthcare - Longevity Research, AI & Healthcare - Brain Modelling, AI & Healthcare - Digital Pathology and 5 more.
Sep 13, 2026, 3 items
The MAVERICK study, presented at the #WCLC26 conference, compared prophylactic cranial irradiation (PCI) with MRI brain surveillance for patients with small cell lung...
Also covers Oncology - PCI Era Ends: MAVERICK Study Results, Oncology - MAVERICK Study: MRI Surveillance for SCLC.
Sep 12, 2026, 6 items
Lung cancer research has made significant strides in recent years, with several breakthroughs in understanding the disease and developing new treatments.
Also covers Medical Research - Debates in Mesothelioma Treatment, Medical Research - Clinical Map of Key Questions at WCLC 2026, Medical Research - Obesity "Memory" and Weight Regain and 2 more.
Sep 10, 2026, 10 items
Evidence-based messaging principles, combined with automated digital outreach, can significantly improve annual wellness visit scheduling rates while reducing...
Also covers The Future of Drug Discovery, Personalized Medicine for Families, High-Desert Weed Season and 6 more.
Sep 8, 2026, 10 items
Initiative W will focus on testing biological AI before release, in realistic research workflows, screening DNA/RNA by function, not only by sequence similarity, and...
Also covers Pan-RAS Inhibitors Landscape Update, New Virus Linked to Flu-like Illness and Low Platelets, #WCLC26 Abstracts to Watch and 6 more.
Sep 7, 2026, 8 items
AI in healthcare is transforming the way medical professionals diagnose and treat patients.
Also covers Latin American Session at IASLC #WCLC26, Maintenance after CAR T, New Review on Emerging Neurotechnology for Sleep Disturbances and 4 more.
Sep 6, 2026, 9 items
Autoimmune disease genetics research has made significant progress in recent years, with a study mapping 6.3 million records into distinct clusters, not one shared...
Also covers Premature Folding in Human Cortex, HOT OFF THE PRESS, Radiotherapy and Immunotherapy and 5 more.
Sep 6, 2026, 10 items
Novartis's pelacarsen, a monthly shot to lower lipoprotein(a), failed its Phase 3 outcomes trial.
Also covers Medical News - KOL Reactions to ETCAMAH Approval, Medical News - Voice Disorders and Cognitive Impairment, Medical News - Adagrasib + Cetuximab Withdrawal and 6 more.
Sep 6, 2026, 11 items
Climate change is one of the greatest threats to human health, and its impact on patients with respiratory health conditions should not be underestimated.
Also covers AI - Evaluating Lakehouse Agents, Health - Personalized Medicine, Healthcare - N-of-1 Medicine and 7 more.
Sep 6, 2026, 10 items
A 3-RCT meta-analysis of ctDNA-positive subgroups in adjuvant trials shows a strengthened OS signal.
Also covers Technical Update: OS Signal in Adjuvant Trials, Technical Update: Prostate Cancer Treatment, Technical Update: Migraine vs. Tension Headache and 6 more.
Sep 6, 2026, 5 items
Recent clinical trials have shown promising results in various fields of medicine. This article summarizes key findings from recent trials.
Also covers Longevity Research - PROSPR Program, Clinical Trials - AI-Human Collaboration, Clinical Trials - HistoPLUS and 1 more.
Sep 6, 2026, 10 items
Event Destination API endpoints have been launched, enabling webhooks to be sent to specified URLs when account changes occur.
Also covers MAPKeeper-301 Trial - Atebimetinib Efficacy, Insurance Coverage - Patient Advocacy, Owkin's CEO at Nature Conferences and 6 more.
Sep 6, 2026, 10 items
ADCs (Antibody-Drug Conjugates) are a type of cancer treatment that combines an antibody with a cytotoxic drug.
Also covers AI/ML - Magnetohydrodynamics, AI/ML - Ideal MHD, AI/ML - OCUDU Lab Testing Services and 6 more.
Sep 6, 2026, 10 items
The announcement concerns a partnership between Ronalfa and Kim Branson following their presentation at the SynBioBeta 2026 main stage.
Also covers Finance - Physician Wealth Exposure, Chemistry Modeling - Reaction Prediction Model Release, Salary Discussion - Practice Economics and 6 more.
Sep 6, 2026, 7 items
OpenMed AI has updated its platform. This update includes a redesigned interface.
Also covers AI for Literature Review - Responsible Use in SciSpace, Oncology - I-SPY2 Trial Update on Breast Cancer Treatment, Oncology - INDIBLADE Trial for Bladder Preservation in MIBC and 3 more.
Sep 6, 2026, 6 items
Glass 5.6 Max achieved the highest score on the Harvard-Stanford ARISE Medical AI Superintelligence Test (MAST), outperforming other systems in clinical judgment...
Also covers Corporate Information - Sanofi Q2 2026 Results, AI in Biology - Expanding Engineering Capabilities, Medical Data - Longitudinal MRI Comparison and 2 more.
Sep 6, 2026, 9 items
Manual systematic literature reviews for drug evaluation are time-consuming. They involve weeks of searching, screening, and extraction, with additional effort for...
Also covers Clinical AI Agents - Building and Application, Cheminformatics - Binding Affinity Prediction, Throne Science - Project Update and 5 more.
Sep 6, 2026, 10 items
The August issue of NEJM Catalyst covers a range of topics in healthcare, including physician leadership, behavioral health, and the impact of AI on care costs.
Also covers Physician Leadership - Evolving Role in U.S. Hospitals, Lung Cancer Treatment - Sac-TMT/Pembro vs. Chemo/IO, Cancer Research - Targeted Therapies and 6 more.